Market outlook of the IVD market in Europe
Technavio’s market research analyst predicts the IVD market in Europe to grow at a CAGR of around 5% during the forecast period. The market is growing due to patient-driven demands such as managing obesity-related illnesses such as cardiovascular diseases, diabetes, and fertility issues. It is estimated that in the UK around 27% of the adults are obese. This has increased the demand of blood-glucose monitors, digital ovulation tests for fertility, and biomarkers test to diagnose cardiovascular diseases.
Increased healthcare spending in European countries will boost the growth of this market until 2020. The healthcare expenditure in the European Union (EU15) has been rising steadily in countries such as Norway, where healthcare expenditure, per capita, has been increasing by 1.4% per year. Also, increased medical knowledge has provided access to new technologies, which, in turn, has increased life expectancy.
Geographical segmentation and analysis of the IVD market in Europe
- Germany
- France
- UK
- Italy
- Spain
- Benelux
- Nordic
The IVD sales in Germany accounted for approximately 26% of the IVD market in Europe, and it is also the biggest contributor to this market. The market grew after the amendment in German reimbursement legislation for the prevention of healthcare-associated diseases and increased with better reimbursement conditions for outpatient clinic physicians.
Competitive landscape and key vendors
The IVD market in Europe is highly fragmented with intense competition among large and small vendors. These vendors form partnerships and develop products to maintain their market share. Market players are focusing on product development and marketing strategies to improve their position in the market. Advances in technology in IVD devices is expected to increase competition among the vendors during the forecast period.
The leading vendors in the market are -
- Abbott Diagnostics
- Beckton Dickinson
- Beckman Coulter
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
Other prominent vendors in the market include Abaxis, A. Menarini Diagnostics, Acon Laboratories, BD, Bio-Rad Laboratories, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, DiagCor, Helena Laboratories, Hologic, Life Technologies, Landwind Medical, Mindray, i-Sens, Nipro Diagnostics, Randox Laboratories, Span Diagnostics, Snibe Diagnostics, Sysmex, Trivitron Healthcare, and URIT.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the IVD market in Europe?
- What are the key market trends impacting the growth of the IVD market in Europe?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the vendors in the IVD market in Europe?
- What are the key outcomes of the five forces analysis of the IVD market in Europe?
Technavio also offers customization on reports based on specific client requirement.
Related reports
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 06: Market segmentation by application
- POCT devices market in Europe
- Immunodiagnostics market in Europe
- Blood glucose monitoring devices market in Europe
- Molecular diagnostics market in Europe
- Hematology devices market in Europe
- Microbiology devices market in Europe
- Tissue diagnostics market in Europe
- Coagulation testing devices market in Europe
PART 07: Geographical segmentation
- IVD market in Germany
- IVD market in France
- IVD market in UK
- IVD market in Italy
- IVD market in Spain
- IVD market in Benelux
- IVD market in Nordic countries
PART 08: Market drivers
- High prevalence of chronic diseases and infections
- Focus on early diagnosis and prevention
- Rise in public awareness
PART 09: Impact of drivers
PART 10: Market challenges
- Competition among vendors and SMEs
- Reimbursement and pricing structure
- Lack of skill in using POC IVD devices
- Limitations of POCT technology
PART 11: Impact of drivers and challenges
PART 12: Market trends
- Focus on real-time and digitalized treatment
- Use of DNA probe-based diagnostics
- Increase in M&A
PART 13: Vendor landscape
- Competitive scenario
- Abbott Diagnostics
- Beckman Coulter
- Becton, Dickinson
- Roche Diagnostics
- Siemens Healthcare
- Thermo Fisher Scientific
- Other prominent vendors
PART 14: Appendix
PART 15: Explore Technavio